Skip to content

Effect of Eliminating Gastric Residual Volume Monitoring on Ventilator Associated Events

Effect of Eliminating Routine Gastric Residual Volume Monitoring on Ventilator-associated Events in Patients Receiving Enteral Feeding

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06059040
Enrollment
160
Registered
2023-09-28
Start date
2023-10-01
Completion date
2024-01-01
Last updated
2023-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventilator Associated Pneumonia

Brief summary

The aims of this study are to investigate the effect of eliminating routine GRV monitoring on VAEs in patients receiving MV and early EF, Determine the effect of eliminating routine GRV monitoring on nutritional adequacy in patients receiving MV and early EF and evaluate the effect of eliminating routine GRV monitoring on feeding intolerance in patients receiving enteral feeding.

Detailed description

Early enteral nutrition (EN) is consistently recommended as first line nutrition therapy in critically ill patients since it favorably alters outcome, providing both nutrition and non-nutrition benefits. However, critically ill patients receiving mechanical ventilation (MV) are at risk for regurgitation, pulmonary aspiration, and eventually ventilator-associated pneumonia (VAP). EN may increase these risks when gastrointestinal (GI) dysfunction is present. Gastric residual volume (GRV) is considered a surrogate parameter of GI dysfunction during the progression of enteral feeding in the early phase of critical illness and beyond. About 62% of critically ill patients receive enteral nutrition (EN) and in patients on MV, enteral feeding was connected to a threefold increase in the development of VAP. A new surveillance definition of ventilator-associated events (VAE) was introduced by the National Healthcare Safety Network (NHSN) in 2013 to identify patients who develop complications of MV. It outlines the various events in a step-by-step fashion, beginning with ventilator-associated complications (VAC), moving on to infectious complications (IVAC), and finally VAP. According to the NHSN, VAEs occur within 9% to 40% of mechanically ventilated patients

Interventions

PROCEDUREeliminating gastric residual volume monitoring

eliminating gastric residual volume monitoring from routine care

Sponsors

Damanhour University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

A parallel randomized controlled design will be used in this study.

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Adults (aged≥18 years) * Newly admitted mechanically ventilated patients who are attached to a mechanical ventilator for at least 48 hours. * Starting enteral nutrition via a nasogastric tube within 36 hours after intubation.

Exclusion criteria

* Abdominal surgery within the past month. * History of esophageal, duodenal, pancreatic, or gastric surgery. * Bleeding from the esophagus, stomach, or bowel. * Enteral nutrition via a jejunostomy or gastrostomy. * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
eliminating gastric residual volume monitoring on ventilator associated events3 monthuse centers for disease control and prevention (CDC) calculators for evaluating VAE version 9.0 2021

Secondary

MeasureTime frameDescription
eliminating gastric residual volume monitoring on nutritional adequacy3 monthevaluation daily caloric requirement by body mass index that calculated using the equation (Weight in kg /height in cm) 2
eliminating gastric residual volume monitoring on incidence of feeding intolerance indicators3 monthevaluation of abdominal circumference, abdominal distension, bowel sounds, the episodes of vomiting and diarrhea

Contacts

Primary ContactEnas Abdel sadek, Demonstrator
Enas_shoeab@nur.edu.dam.eg01093168809
Backup ContactDr. Sahar Younes, Assistant Professor
sahar.younes.ramadan@nur.dmu.edu.eg01005551564

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026